Pyxis Oncology, Inc. Revenue 2024–2025
Pyxis Oncology, Inc. annual/quarterly revenue history and growth rate from 2024 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Pyxis Oncology, Inc. revenue for the quarter ending June 30, 2025 was 2.8 M.
- Pyxis Oncology, Inc. annual revenue for 2025 was 13.9 M, a 14.17% decrease from 2024.
- Pyxis Oncology, Inc. annual revenue for 2024 was 16.1 M.
Pyxis Oncology, Inc. (PYXS) — Frequently Asked Questions
Pyxis Oncology, Inc. (PYXS) is a publicly traded US company. It has a market capitalization of $102M. In fiscal 2025 it reported revenue of $14M and net income of -$80M. Explore PYXS's stock price, financial statements, earnings history, margins and key ratios below.
What is Pyxis Oncology, Inc.'s market cap?
Pyxis Oncology, Inc. (PYXS) has a market capitalization of $102M.
What is the PYXS stock price?
PYXS trades at $1.65 (-1.50% on the day).
How much revenue does Pyxis Oncology, Inc. make?
Pyxis Oncology, Inc. reported revenue of $14M in fiscal 2025.
Is PYXS profitable?
In fiscal 2025, Pyxis Oncology, Inc. reported net income of -$80M.